Improving the production of natural compounds for potential therapies
Directed Evolution of Isoprenoid Biosynthesis
This study is exploring a new way to make important natural compounds called isoprenoids, which can be used in medicines, by using a special method to improve the production process, so that new and better treatments might be developed for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10849823 on NIH RePORTER |
What this research studies
This research focuses on enhancing the biosynthesis of isoprenoids, which are vital components in many natural products with medicinal properties. By utilizing a newly developed pathway called the Alcohol Dependent Hemiterpene (ADH) pathway, the researchers aim to simplify the production process and overcome existing challenges in isoprenoid synthesis. The approach involves directed evolution techniques to modify enzymes and expand their capabilities, ultimately allowing for a greater variety of isoprenoid structures that could lead to new therapeutic options. Patients may benefit from the development of novel drugs derived from these enhanced natural products.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new treatments targeting conditions related to isoprenoid-derived compounds.
Not a fit: Patients with conditions that do not involve isoprenoid-related therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of new and more effective therapeutic agents derived from isoprenoids.
How similar studies have performed: Other research has shown promise in enhancing natural product biosynthesis through similar engineering approaches, indicating potential for success in this area.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Williams, Gavin J — North Carolina State University Raleigh
- Study coordinator: Williams, Gavin J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.